These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
894 related articles for article (PubMed ID: 17337065)
1. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27. Collaborative Ocular Melanoma Study Group Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065 [TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22. Collaborative Ocular Melanoma Study Group Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376 [TBL] [Abstract][Full Text] [Related]
3. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804 [TBL] [Abstract][Full Text] [Related]
4. Ocular complications after iodine brachytherapy for large uveal melanomas. Puusaari I; Heikkonen J; Kivelä T Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335 [TBL] [Abstract][Full Text] [Related]
5. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577 [TBL] [Abstract][Full Text] [Related]
6. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534 [TBL] [Abstract][Full Text] [Related]
7. Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. Gilson MM; Diener-West M; Hawkins BS Ophthalmic Epidemiol; 2007; 14(4):251-7. PubMed ID: 17896305 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Sobrin L; Schiffman JC; Markoe AM; Murray TG Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708 [TBL] [Abstract][Full Text] [Related]
9. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques. Puusaari I; Heikkonen J; Kivelä T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045 [TBL] [Abstract][Full Text] [Related]
10. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Hawkins BS; Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284 [TBL] [Abstract][Full Text] [Related]
11. Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma. Oliver SC; Young TA; Kobe LH; Leu MY; Lee SP; Chun MW; Straatsma BR Am J Clin Oncol; 2008 Oct; 31(5):488-92. PubMed ID: 18838887 [TBL] [Abstract][Full Text] [Related]
12. (125)I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain. Correa R; Pera J; Gómez J; Polo A; Gutiérrez C; Caminal JM; Modolell I; Navarro V; Guedea F Brachytherapy; 2009; 8(3):290-6. PubMed ID: 19428308 [TBL] [Abstract][Full Text] [Related]
13. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA; Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813 [TBL] [Abstract][Full Text] [Related]
14. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study. Kivelä T; Puusaari I; Damato B Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535 [TBL] [Abstract][Full Text] [Related]
15. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study. Finger PT; Berson A; Szechter A Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222 [TBL] [Abstract][Full Text] [Related]
16. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome]. Kreissig I; Rose D; Simader E Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481 [TBL] [Abstract][Full Text] [Related]
17. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM; Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893 [TBL] [Abstract][Full Text] [Related]
18. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [TBL] [Abstract][Full Text] [Related]
19. Ocular complications following I-125 brachytherapy for choroidal melanoma. Wen JC; Oliver SC; McCannel TA Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865 [TBL] [Abstract][Full Text] [Related]
20. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Cugati S; Mitchell P; Rochtchina E; Tan AG; Smith W; Wang JJ Ophthalmology; 2006 Nov; 113(11):2020-5. PubMed ID: 16935334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]